[BIO-B] YoY Quarter Result on 30-Jun-2023 [#Q2]

Stock
[BIO-B] Bio-Rad Laboratories, Inc.
Announcement Date
04-Aug-2023
Financial Year
2023
Quarter
30-Jun-2023 [#Q2]
Profit Trend
QoQ- -1,785.35%
YoY- -25.35%
Quarter Report
BIO-B's Result
BIO-B's Financial Summary
View:
Show?
Quarter Result
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Revenue 638,476 681,110 691,099 715,931 536,880 572,619 575,911 1.73%
PBT -2,786,281 -1,500,427 -1,222,880 1,156,775 1,245,945 769,601 340,086 -
Tax -620,795 -338,176 -295,696 242,661 279,516 170,791 72,043 -
NP -2,165,486 -1,162,251 -927,184 914,114 966,429 598,810 268,043 -
Tax Rate - - - -20.98% -22.43% -22.19% -21.18% -
Total Cost 2,803,962 1,843,361 1,618,283 -198,183 -429,549 -26,191 307,868 44.46%
Ratio Analysis
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
NP Margin -339.16 -170.64 -134.16 127.68 180.01 104.57 46.54 -
Per Share
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
EPS -76.26 -39.59 -31.12 30.71 32.59 20.08 8.99 -
EPS Diluted -76.26 -39.59 -31.12 30.32 32.15 19.86 8.87 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.